Better safety for patients through EU-funded research
The results of the Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium (PROTECT) project, that were published in a series of different medical journals, are making a difference in the assessment of benefits and risks of medicines available for patients in Europe. The goal of this project was to develop innovative methods to improve and strengthen the monitoring of the benefits and risks of medicines marketed in the European Union. PROTECT concentrated on improving early and proactive signal detection, establishing a framework for pharmacoepidemiology studies, developing methods for continuous benefit-risk monitoring of medicines and enhancing data collection directly from patients.
Click on this link for more information.
